The therapeutic potential for targeting group 2 innate lymphoid cells in asthma

T Matsuyama, H Matsuyama, Y Dotake… - Frontiers in …, 2022 - frontiersin.org
T helper type 2 cells (Th2 cells) and group 2 innate lymphoid cells (ILC2s) play an important
role in the pathophysiology of asthma, including airway eosinophilic inflammation. ILC2s are …

Group 2 innate lymphoid cells in human asthma

A Iwata, Y Toda, H Furuya, H Nakajima - Allergology International, 2023 - jstage.jst.go.jp
abstract Asthma is characterized by increased airway hyperresponsiveness, reversible
airflow limitation, and remodeling due to allergic airway inflammation. Asthma has been …

ILCs and allergy

H Kabata, Y Motomura, T Kiniwa, T Kobayashi… - Innate lymphoid …, 2022 - Springer
The recent discovery of new innate lymphoid cells (ILCs) has revolutionized the field of
allergies. Since most allergic diseases induce a type 2 immune response, Th2 cells, which …

Group 2 innate lymphoid cells in nasal polyposis

WW Stevens, A Kato - Annals of Allergy, Asthma & Immunology, 2021 - Elsevier
Objective Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a chronic
type 2 inflammatory response in the paranasal sinuses. Group 2 innate lymphoid cells …

Successful treatment of mepolizumab-and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab

S Mikura, T Saraya, Y Yoshida, M Oda, M Ishida… - Internal …, 2021 - jstage.jst.go.jp
A 45-year-old man with allergic bronchopulmonary aspergillosis (ABPA) was treated with
oral prednisolone (PSL)(30 mg/day), inhaled corticosteroids, and long-acting beta2 …

[HTML][HTML] Exacerbation of eosinophilic granulomatosis with polyangiitis after administering dupilumab for severe asthma and eosinophilic rhinosinusitis with nasal …

S Tanaka, T Tsuji, S Shiotsu, T Yuba, N Hiraoka - Cureus, 2022 - ncbi.nlm.nih.gov
Eosinophilic granulomatosis with polyangiitis (EGPA) refers to systemic vasculitis in patients
with bronchial asthma and eosinophilic rhinosinusitis. Dupilumab has been approved for the …

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi

S Adachi, C Oshikata, T Kaneko… - Allergy, Asthma & Clinical …, 2022 - Springer
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is characterized by a
necrotizing vasculitis with tissue and peripheral blood eosinophilia affecting small and …

Clinical effects and immune modulation of biologics in asthma

N Harada, J Ito, K Takahashi - Respiratory Investigation, 2021 - Elsevier
Asthma is considered a syndrome composed of heterogeneous disorders involving complex
chronic airway inflammation. Patients with severe asthma, prolonged symptoms, and …

[HTML][HTML] Upregulation of IL-4 receptor signaling pathway in circulating ILC2s from asthma patients

R Baba, H Kabata, Y Shirasaki, T Kamatani… - Journal of Allergy and …, 2022 - Elsevier
Background Group 2 innate lymphoid cells (ILC2s) produce type 2 cytokines by stimulation
with epithelial cell–derived cytokines and are implicated in the pathogenesis of various …

The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma

K Nakagome, M Nagata - Biomolecules, 2024 - mdpi.com
Bronchial asthma is characterized by airway inflammation, airway hyperresponsiveness,
and reversible airway obstruction. Eosinophils contribute to the pathogenesis of airway …